MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    The Polymorphism of SREBF1 Gene rs11868035 G/A Is Associated with susceptibility to Parkinson’s disease in a Chinese Population

    F. Lou, M. Li, XG. Luo, Y. Ren (Shenyang, China)

    Objective: The potential association between the single-nucleotide polymorphism of two functional genes (SREBF1gene rs11868035 and USP25 gene rs2823357) and susceptibility to Parkinson’s disease (PD) in…
  • 2018 International Congress

    Determining the effect of the HNMT, STK39 and NMD3 polymorphisms on the incidence of Parkinson’s disease, amyotrophic lateral sclerosis and multiple system atrophy in Chinese populations

    Y.P. Chen, B. Cao, R.W. Ou, Q.Q. Wei, X.P. Chen, B. Zhao, Y. Wu, W. Song, H.F. Shang (Chengdu, People’s Republic of China)

    Objective: To investigate associations between 3 variants (HNMT Thr105Ile, STK39 rs2390669, and NMD3 rs34016896) and PD, multiple system atrophy (MSA) as well as amyotrophic lateral…
  • 2018 International Congress

    Mitochondrial phenotype related to the A30P alpha-synuclein mutation as a patient-derived cellular model of Parkinson’s disease

    B. Santos, P. Barbuti, P. Antony, J. Arias, A. Hummel, J. Schwamborn, R. Krüger (Belval, Luxembourg)

    Objective: Our study aims to perform detailed phenotyping of the A30P alpha-synuclein familial case of PD, allowing to identify underlying mechanisms of the disease that…
  • 2018 International Congress

    Resting state networks abnormalities among healthy LRRK2 mutation carriers

    A. Thaler, Y. Jacob, T. Gurevich, R. Helmich, B. Bloem, A. Orr-Urtreger, N. Giladi, L. Yahimovich, A. Mirelman, T. Hendler (Tel-Aviv, Israel)

    Objective: To assess the integrity of resting state networks in non-manifesting carriers of the G2019S mutation in the LRRK2 gene. Background: Non-manifesting first degree relatives…
  • 2018 International Congress

    Evidence for dysregulation of inflammatory mechanisms involving the NF-κB complex in the living parkinsonian brain

    S. Benoit, H. Xu, R. Alexandrova, G. Kaur, B. Thiruvahindrapuram, M. Hebb (London, ON, Canada)

    Objective: Sequence RNA in cortical samples taken from living PD patients to detect significant differentially expressed genes (DEGs) and altered biological pathways when compared to…
  • 2018 International Congress

    Nucleotide repeats as genetic risk factors in a Swedish Parkinson’s disease cohort

    J. Laffita Mesa, L. Brodin, P. Svenningsson (Stockholm, Sweden)

    Objective: To search for abnormal NRE in the following genes: ATXN2, ATXN3, CACNA1A, TBP, c9orf72, PRNP, POLG1A and TOMM40 in a Swedish PD cohort. Background:…
  • 2018 International Congress

    Nurr1 gene: A new research target for Parkinson’s disease

    W. Le (Dalian, China)

    Objective: The objective of our study is to determine if Nurr1 gene, a transcription factor essential for dopamine (DA) neuron development and survival, is a…
  • 2018 International Congress

    Acid sphingomyelinase deficiency rescues mitochondrial dysfunction in gba-/- zebrafish (Danio rerio)

    M. Keatinge, L. Trollope, H. Mortiboys, O. Bandmann (Sheffield, United Kingdom)

    Objective: To determine the interaction between glucocerebrosidase deficiency and acid sphingomyelinase deficiency in a tractable vertebrate model system of Parkinson's disease. Background: Heterozygous glucocerebrosidase (GBA)…
  • 2018 International Congress

    Expanding the canvas of PARKIN mutations and clinical phenotypes in familial and early onset Parkinson’s disease patients

    S. Pandey, L. Tomar, S. Kumar, B. Thelma (New Delhi, India)

    Objective: To identify PARKIN mutations in PD patients with familial history (FPD) and early onset PD patients with no family history (EOPD; ≤50 years) and…
  • 2018 International Congress

    A unique case of DAT positive Parkinson’s disease along with a mutable Huntington’s gene

    P. Prakash, S. Baser, M. Flaherty, T. Leichliter (Pittsburgh, PA, USA)

    Objective: The aim of this abstract is to report a unique case of DAT positive Parkinson’s disease with a mutable Huntington’s gene. Background: Huntington’s disease…
  • « Previous Page
  • 1
  • …
  • 1322
  • 1323
  • 1324
  • 1325
  • 1326
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley